Dyslipidemia, dysregulated adipokine secretions and alteration in glucagon and adropin concentrations are important obesity-related factors in the pathophysiology of human T2DM [9, 10]; however, their roles in the pathophysiology of FDM are relatively unknown [11]. Here, ENHO is linked to type 2 diabetes mellitus.